People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

A new facility opened in Wallingford Saturday afternoon that treats mental health conditions with low doses of Ketamine.

Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Actor Matthew Langford Perry was born on August 19, 1969, and died on October 28, 2023. His role as Chandler Bing on the NBC comedy Friends (1994–2004) brought him international recognition.

This article explores insights from Richmond-area therapists on Ketamine-Assisted Psychotherapy (KAP) and EMDR therapy, ...

TARA Mind launched its Mental Health Savings Calculator, a tool to help employers combat the rising costs of untreated mental health conditions.

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.